Global Tuberculosis Infection Testing Market Growth (Status and Outlook) 2024-2030

Global Tuberculosis Infection Testing Market Growth (Status and Outlook) 2024-2030

The global Tuberculosis Infection Testing market size is projected to grow from US$ 2581.2 million in 2023 to US$ 3469.5 million in 2030; it is expected to grow at a CAGR of 4.3% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Tuberculosis Infection Testing Industry Forecast” looks at past sales and reviews total world Tuberculosis Infection Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Tuberculosis Infection Testing sales for 2024 through 2030. With Tuberculosis Infection Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Infection Testing industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis Infection Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Infection Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Infection Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Infection Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Infection Testing.

United States market for Tuberculosis Infection Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Tuberculosis Infection Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Tuberculosis Infection Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Tuberculosis Infection Testing players cover Danaher, Becton Dickinson, Bio-Rad, Qiagen and Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Infection Testing market by product type, application, key players and key regions and countries.

Segmentation by type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others

Segmentation by application
Hospitals and Clinics
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Danaher
Becton Dickinson
Bio-Rad
Qiagen
Thermo Fisher Scientific
Roche
Oxford Immunotec
Hologic
Hain Lifescience
Genedrive plc
Akonni Biosystems
Creative Diagnostics

Please note: The report will take approximately 2 business days to prepare and deliver.